Somatostatin receptor scintigraphy in thyroid eye disease

Thyroid

Volumn 8, Issue 6, 1998, Pages 549-552

  Kahaly, George J ^a   Förster, Gregor J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETREOTIDE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031863398     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.549     Document Type: Conference Paper

References (14)

1. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC 1995 Somatostatin receptor scintigraphy. Nucl Med Annual 1-50.
2. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ 1989 Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264:949-953.
3. Kahaly G, Hansen Ch, Felke B, Dienes HP 1994 Immunohistochemical Staining of retrobulbar adipose tissue in Graves' ophthalmopathy. Clin Immunol Immunopathol 73:53-62.
4. Otto E, Ochs K, Hansen C, Wall J, Kahaly G 1996 Orbitaltissue derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 84:3255-3260.
5. Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A 1995 Indium-111-Pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 36:550-554.
6. Kahaly G, Diaz M, Just M, Beyer J, Lieb W 1995 Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy. Thyroid 5:107-111.
7. Kahaly G 1996 New imaging procedures in thyroid-associated ophthalmopathy. Orbit 15:165-175.
8. Postema PTE, Krenning EP, Wijngaarde R, Kooy PPM, Oei HY, van den Bosch WA, Reubi JC, Wiersinga WM, Hooijkaas H, van der Loos T, Poublon RML, Lamberts SWJ, Hennemann G 1994 [111In-DTPA-D-Phel] Octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity. J Clin Endocrinol Metab 79:1845-1851.
9. Kahaly G, Gorges R, Diaz M, Hommel G, Bockisch A 1998 Indium-111-Pentetreotide in Graves' Disease. J Nucl Med 39:533-536.
10. Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E 1997 Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-Octreotide. Thyroid 7:21-29.
11. Kahaly G, Pitz S, Müller-Forell, Hommel G. 1996 Randomized trial of intravenous immunoglobulins versus prednisolone in Graves' ophthalmopathy. Clin Exp Immunol 106:197-202.
12. Krassas GE, Dumas A, Pontikides N, Kaltsas Th 1995 Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 42:571-580.
13. Krassas GE, Kaltsas T, Dumas A. Pontikides N, Tous G 1997 Lanreotide in the treatment of patients with thyroid eye disease. Eur J Endocrinol 136:416-422.
14. Hansen C, Fraiture B, Rouhi R, Otto E, Förster G, Kahaly G 1997 HPLC glycosaminoglycan analysis in patients with Graves' disease. Clin Sci 92:511-517.